Chiara Benvenuti
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Development and Preliminary Validation of a Tool to Assess Barriers and Facilitators to Participation in Adjuvant Endocrine Therapy Switch Trials.
Journal: Current oncology (Toronto, Ont.)
Published: May 05, 2026
From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching.
Journal: Tumori
Published: December 15, 2025
[18F]FDG PET/CT as a biomarker for response evaluation in neoadjuvant treatment of early breast cancer: could it become a game-changer in the scenario of the emerging (de)-escalation strategies?
Journal: La Radiologia medica
Published: April 15, 2025
Sex-Related Differences in Immunotherapy Toxicities: Insights into Dimorphic Responses.
Journal: Cancers
Published: February 11, 2025
Beyond failure of endocrine-based therapies in HR+/HER2 negative advanced breast cancer: What before chemotherapy? A glimpse into the future.
Journal: Critical reviews in oncology/hematology
Published: November 04, 2024
Incorporating radiomic MRI models for presurgical response assessment in patients with early breast cancer undergoing neoadjuvant systemic therapy: Collaborative insights from breast oncologists and radiologists.
Journal: Critical reviews in oncology/hematology
Published: October 03, 2024
Pre-existing and emerging immune-mediated diseases in patients with breast cancer undergoing cyclin-dependent kinases 4/6 inhibitors and endocrine therapy.
Journal: The oncologist
Published: September 30, 2024
Unveiling the Potential of Cyclin-Dependent Kinases 4 and 6 Inhibitors Beyond Progression in Hormone Receptor Positive/Human Epidermal Growth Factor Negative Advanced Breast Cancer - A Clinical Review.
Journal: Current treatment options in oncology
Published: August 21, 2024
Empowerment, Pain Control, and Quality of Life Improvement in Early Triple-Negative Breast Cancer Patients through Pain Neuroscience Education: A Prospective Cohort Pilot Study Protocol (EMPOWER Trial).
Journal: Journal of personalized medicine
Published: May 30, 2024
Last Updated: 09/26/2026